Unknown

Dataset Information

0

Expert recommendations for biomarker evaluation of advanced non-small cell lung cancer in Thailand

ABSTRACT:

SUBMITTER: Shuangshoti S 

PROVIDER: S-EPMC12337075 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer.
| S-EPMC8512462 | biostudies-literature
Unknown Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.
| S-EPMC8512472 | biostudies-literature
Unknown Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
| S-EPMC10724778 | biostudies-literature
Unknown XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer.
| S-EPMC3809298 | biostudies-literature
Unknown Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study.
| S-EPMC8117590 | biostudies-literature
Unknown Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer.
| S-EPMC12541564 | biostudies-literature
Unknown Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer.
| S-EPMC7815365 | biostudies-literature
Unknown Expert consensus on perioperative treatment for non-small cell lung cancer.
| S-EPMC9359944 | biostudies-literature
Unknown Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer.
| S-EPMC10880349 | biostudies-literature
Unknown Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
| S-EPMC6276906 | biostudies-literature